Ray Therapeutics vs Rejoni
Ray Therapeutics vs Rejoni, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Ray Therapeutics is on 53/100 and Rejoni on 46/100.
Where each one leads
Ray Therapeutics
- our overall score: 53/100 against 46/100
- domain rating: 29/100 against 17/100
- funding raised: $243M against $25.0M
Rejoni
- agent readiness: 26/100 against 21/100
At a glance
| Measure | Ray Therapeutics | Rejoni |
|---|---|---|
| What it is | Pioneering vision restoration therapies for severe retinal degenerations. | Elevating uterine health through innovative biomaterial therapies. |
| Category | Biotechnology, Pharmaceuticals, Healthcare, Medical Devices | Biotechnology, Healthcare, Medical Devices, Biotech |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Hardware |
| Founded | 2021 | 2018 |
| Headquarters | Berkeley, USA | Bedford, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | Ray Therapeutics | Rejoni |
|---|---|---|
| Employees | Not published | 19 |
| Total funding | $243M | $25.0M |
| Latest round | Series B | Funding Round |
| LinkedIn followers | Not published | 870 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Ray Therapeutics | Rejoni |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 53/100 | 46/100 |
| Traction | 40/100 | 50/100 |
| Team | 50/100 | Not published |
| Search visibility | 14/100 | 35/100 |
| Quality | 68/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | F (26/100) |
| Domain ratingLink authority, 0-100 | 29/100 | 17/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Ray Therapeutics | Rejoni |
|---|---|---|
| CDN | Cloudflare | Cloudflare |
| CMS | WordPress | Webflow |
| Frameworks | Jquery | Not detected |
| Analytics | Google Analytics 4 | Not detected |
Ray Therapeutics vs Rejoni: common questions
Which is better, Ray Therapeutics or Rejoni?
On our 0-100 score Ray Therapeutics rates higher (53/100 against 46/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do Ray Therapeutics and Rejoni compare on the numbers?
Ray Therapeutics leads on our overall score (53/100 against 46/100), domain rating (29/100 against 17/100), funding raised ($243M against $25.0M). Rejoni leads on agent readiness (26/100 against 21/100).
Read the full Ray Therapeutics review and pricing or the Rejoni review and pricing. You can also browse other Ray Therapeutics alternatives we track.